Twist Bioscience
TWST
244 hedge funds and large institutions have $6.4B invested in Twist Bioscience in 2021 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 95 increasing their positions, 66 reducing their positions, and 41 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
44% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 66
15% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 41
10% more capital invested
Capital invested by funds: $5.82B → $6.4B (+$578M)
2% more funds holding
Funds holding: 239 → 244 (+5)
1.82% more ownership
Funds ownership: 96.61% → 98.43% (+1.8%)
4% more call options, than puts
Call options by funds: $18.7M | Put options by funds: $18M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$137M |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$56M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
+$53.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.6M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$18.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$115M |
| 2 |
Two Sigma Investments
New York
|
-$25.1M |
| 3 |
BlackRock
New York
|
-$23.5M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$14.7M |
| 5 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$13.2M |
TWST Hedge Fund Activity: Q2 2021 in Review
244 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q2 2021, worth a combined $6.4B — up 9.9% from $5.82B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new TWST positions and 41 closed out — a net gain of 6 holders — while 95 added to existing stakes and 66 trimmed.
The largest buyer was Capital World Investors, adding an estimated $137M. The largest seller was ARK Investment Management, cutting an estimated $115M.
- 244 institutional investors held Twist Bioscience (TWST) as of Q2 2021, up from 239 in Q1 2021.
- Funds reported $6.4B of Twist Bioscience stock for Q2 2021, up 9.9% quarter-over-quarter.
- 47 funds opened new Twist Bioscience positions in Q2 2021 and 41 closed out, a net change of +6 holders.
- The largest Twist Bioscience buyer in Q2 2021 was Capital World Investors, an estimated $137M added.
- The largest Twist Bioscience seller in Q2 2021 was ARK Investment Management, an estimated $115M sold.
Based on aggregated 13F filings for Q2 2021.